| Literature DB >> 33354475 |
Frideriki Poutoglidou1, Maria Piagkou2, Trifon Totlis3, Maria Tzika4, Konstantinos Natsis4.
Abstract
The present systematic review and meta-analysis provides a comprehensive assessment of the sciatic nerve (SN) variants relative to the piriformis muscle (PM) and compares those variants' prevalence among different geographical populations with respect to gender and laterality. A database search was conducted to identify cadaveric studies pertinent to SN variants relative to the PM. A total of 44 articles were included. The typical morphological pattern (type A, with the SN passing undivided below the PM) was found to be the most common variant, with 90% pooled prevalence. SN variants were more common among East Asians, with a 31% pooled prevalence of total variants. No significant differences were established with respect to gender and laterality. In greater than 10% of the population, the SN coursed through or above piriformis. Patients' epidemiological characteristics may predispose them to certain variants. The common peroneal nerve (CPN) is more susceptible to injury during a total hip arthroplasty or a hip arthroscopy where anomalies are encountered. As anatomical variants are commonly associated with piriformis syndrome, they should always be considered during diagnosis and treatment.Entities:
Keywords: abnormality; anatomy; anomaly; piriformis muscle; sciatic nerve; variation
Year: 2020 PMID: 33354475 PMCID: PMC7746330 DOI: 10.7759/cureus.11531
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Figure 1The Beaton and Anson classification system (1937)*
*[3]
Type A: typical morphological pattern, the SN passes below the PM undivided. Type B: the CPN exits through the PM and the TN exits below the PM. Type C: the CPN exits above the PM and the TN and below the PM. Type D: the SN exits through the PM, as a single trunk. Type E: the CPN exits above the PM and the TN through the PM. Type F: the SN passes undivided above the PM
SN: sciatic nerve; PM: piriformis muscle; CPN: common peroneal nerve; TN: tibial nerve
Figure 2PRISMA flowchart summarizing the selection process
PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses
Characteristics of the cadaveric studies included in the systematic review
aNo data reported with respect to geographic region. bData missing from one specimen. c1 additional variant not described in Beaton and Anson classification. d4 additional variants not described in Beaton and Anson classification: a variant with a PM with three muscle bellies and a CPN passing between superficial and intermediate muscle belly and the deep muscle belly passing through the TN; a variant in which the CPN passed between the two bellies of a double-headed PM and the TN passed below the PM; and two variants in which the SN passed below the PM and a supernumerary muscle located just superior to the PM (in the suprapiriform foramen)
Note: types E and F were excluded from the meta-analysis due to the limited number of studies that included them
SN: sciatic nerve; PM: piriformis muscle; CPN: common peroneal nerve; TN: tibial nerve
| Author | Year of publication | Country of population origin | Sample size | Type A, n (%) | Type B, n (%) | Type C, n (%) | Type D, n (%) | Type E, n (%) | Type F, n (%) | Total variations, n (%) |
| Paterson [ | 1893 | Scotland (Europe) | 23 | 20 (87%) | 3 (13%) | - | - | - | - | 3 (13%) |
| Parsons and Keith [ | 1897 | England (Europe) | 138 | 118 (85.5%) | 17 (12.3%) | 3 (2.1%) | - | - | - | 20 (14.4%) |
| Bardeen [ | 1901 | USA | 246 | 220 (89.4%) | 25 (10.2%) | 1 (0,4%) | - | - | - | 26 (10.6%) |
| Trotter [ | 1932 | USA | 464 | 400 (86.2%) | - | - | - | - | - | 64 (13.8%) |
| Beaton and Anson [ | 1937 | USA | 240 | 216 (90%) | 17 (7%) | 5 (2%) | 2 (0.8%) | - | - | 24 (10%) |
| Ming-Tzu [ | 1941 | China (East Asia) | 140 | 92 (65.7%) | 46 (32.9%) | - | 2 (1.4%) | - | - | 48 (34.3%) |
| Misra [ | 1954 | India | 300 | 262 (87.3%) | 18 (6%) | 12 (4%) | 8 (2.7%) | - | - | 38 (12.6%) |
| Kubota et al. [ | 1960 | Japan (East Asia) | 38 | 33 (86.8%) | - | 5 (13.2%) | - | - | - | 5 (13.2%) |
| Anson and McVay [ | 1971 | USA | 2,008 | 1,789 (89.1%) | 201 (10%) | 13 (0.6%) | 5 (0.2%) | - | - | 219 (10.9%) |
| Nizankowski et al. [ | 1972 | Poland (Europe) | 200 | 181 (90.5%) | 8 (4%) | 3 (1.5%) | 5 (2.5%) | 3 (1.5%) | - | 19 (9.5%) |
| Lee and Tsai [ | 1974 | Taiwan (East Asia) | 168 | 118 (70.2%) | 33 (19.6%) | 7 (4.2%) | 3 (1.8%) | 1 (1.5%) | 2 (2.9%) | 50 (29.8%) |
| Pećina [ | 1979 | Croatia (Europe) | 130 | 102 (78.5%) | 27 (20.8%) | 1 (0.7%) | - | - | - | 28 (21.5%) |
| Chiba [ | 1992 | Japan (East Asia) | 511 | 328 (64.2%) | 173 (33.9%) | 10 (2%) | - | - | - | 183 (35.8%) |
| Chiba et al. [ | 1994 | Japan (East Asia) | 442 | 285 (64.5%) | 148 (33.5%) | 9 (2%) | - | - | - | 157 (35.5%) |
| Georgiadis et al. [ | 1996 | USA | 42 | 40 (95.2%) | 2 (4.8%) | - | - | - | - | 2 (4.8%) |
| Gabrielli et al. [ | 1997 | Brazil | 80 | 69 (86.2%) | 9 (11.3%) | 2 (2.5%) | - | - | - | 11 (13.7%) |
| Pokorný et al. [ | 1998 | Czech Republic (Europe) | 51 | 41 (80.4%) | 7 (13.7%) | 2 (3.9%) | 1 (2%) | - | - | 10 (19.6%) |
| Uluutku and Kurtoğlu [ | 1999 | Turkey | 50 | 37 (74%) | 8 (16%) | 5 (10%) | - | - | - | 13 (26%) |
| Okraszewska et al. [ | 2002 | Poland (Europe) | 36 | 29 (80.6%) | 2 (5.6%) | 2 (5.6%) | 3 (8.3%) | - | - | 7 (19.4%) |
| Fishman et al. [ | 2002 | USA | 76 | 65 (85.5%) | - | - | - | - | - | 11 (14.5%) |
| Indrekvam et al. [ | 2002 | Norway (Europe) | 19 | 15 (78.9%) | - | - | - | - | - | 4 (21.1%) |
| Benzon et al. [ | 2003 | USA | 66 | 65 (98.4%) | 1 | - | - | - | - | 1 (1.6%) |
| Ndiaye et al. [ | 2004 | Senegal (Africa) | 20 | 19 (95%) | - | - | - | - | 1 (5%) | 1 (5%) |
| Agur and Dalleya [ | 2005 | 640 | 557 (87%) | 78 (12.2%) | 3 (0.5%) | - | - | - | 81 (12.7%) | |
| Ugrenović et al. [ | 2005 | Serbia-Montenegro (Europe) | 200 | 192 (96%) | 5 (2.5%) | 3 (1.5%) | - | - | - | 8 (4%) |
| Pokorný et al. [ | 2006 | Czech Republic (Europe) | 91 | 72 (79.1%) | 13 (14.3%) | 4 (4.4%) | 2 (2.2%) | - | - | 19 (20.9%) |
| Chukwuanukwu et al. [ | 2007 | Nigeria (Africa) | 52 | 50 (96.2%) | 2 (3.8%) | - | - | - | - | 2 (3.8%) |
| Vincente et al. [ | 2007 | Brazil | 40 | 34 (85%) | 6 (15%) | - | - | - | - | 6 (15%) |
| Pecina et al. [ | 2008 | Croatia (Europe) | 10 | 7 (70%) | 3 (30%) | - | - | - | - | 3 (30%) |
| Güvençer et al. [ | 2008 | Turkey | 50 | 38 (76%) | 7 (14%) | 4 (8%) | - | - | 11 (24%)b | |
| Kukiriza et al. [ | 2010 | Uganda (Africa) | 80 | 62 (77.5%) | - | - | 18 (22,5%) | |||
| Brooks et al. [ | 2011 | Brazil | 40 | 36 (90%) | - | - | 4 (10%) | - | - | 4 (10%) |
| Muthu Kumar et al. [ | 2011 | India | 50 | 50 (100%) | - | - | - | - | - | 0 (0%) |
| Ogeng'o et al. [ | 2011 | Kenya (Africa) | 164 | 147 (89.6%) | 13 (7.9%) | 4 (2.4%) | - | - | - | 17 (10.4%) |
| Patel et al. [ | 2011 | India | 86 | 81 (94.2%) | 5 (5.8%) | - | - | - | - | 5 (5.8%) |
| Sabnis [ | 2012 | India | 140 | 139 (99.3%) | - | 1 (0.7%) | - | - | - | 1 (0.7%) |
| Delabie et al. [ | 2013 | France (Europe) | 104 | 94 (90.4%) | 10 (9.6%) | - | - | - | - | 10 (9.6%) |
| Prathiba et al. [ | 2013 | India | 100 | 92 (92%) | 3 (3%) | 1 (1%) | - | - | 4 (4%) | |
| Adibatti and Sangeetha [ | 2014 | India | 50 | 47 (94%) | - | - | - | - | - | 3 (6%) |
| Desalegn and Tesfay [ | 2014 | Ethiopia (Africa) | 36 | 33 (91.7%) | 2 (5.6%) | - | - | - | - | 2 (5.6%)c |
| Gomes et al. [ | 2014 | Brazil | 40 | 35 (87.5%) | 5 (12.5%) | - | - | - | - | 5 (12.5%) |
| Natsis et al. [ | 2014 | Greece (Europe) | 294 | 275 (93.5%) | 12 (4.1%) | 1 (0.3%) | 1 (0.3%) | - | 1 (0.3%) | 14 (4.7%)d |
| Sulak et al. [ | 2014 | Turkey | 400 | 392 (98%) | 5 (1.3%) | 3 (0.8%) | - | - | - | 8 (1.9%) |
| Lewis et al. [ | 2016 | USA | 102 | 90 (88.2%) | 9 (8.8%) | 3 (2.9%) | - | - | - | 12 (11.8%) |
| Total | 8,257 | 7,067 | 923 | 106 | 37 | 4 | 4 | 1,177 | ||
| Total prevalence (confidence interval) | 90% (83-90%) | 8% (5-10%) | 2% (0-3%) | 1% (0-2%) | 13% (10-16%) | |||||
| I2 | 95% | 93% | ||||||||
| Cochrane’s Q, p-value | 0.00 | 0.00 | ||||||||
Figure 3Prevalence of anatomic variations of the SN relative to the PM
SN: sciatic nerve; PM: piriformis muscle
Subgroup analysis by geographic region
| Geographic region | Type Α | Type Β | Type C | Type D | Total variations |
| Turkey | 85% (CI: 60-100%) | 9% (CI: 0-31%) | 2% (CI: 0-3%) | 0% (CI 0-9%) | 14% (CI: 0-38%) |
| Europe | 88% (CI: 81-91%) | 9% (CI: 6-14%) | 2% (CI: 0-4%) | 1% (CI 0-3%) | 14% (CI: 9-19%) |
| USA | 95% (CI: 84-96%) | 4% (CI: 1-9%) | 1% (CI: 0-3%) | 0% (CI: 0-2%) | 11% (CI: 9-13%) |
| Brazil | 89% (CI: 76-95%) | 8% (CI: 2-18%) | 1% (CI: 0-5%) | 2% (CI: 0-6%) | 13% (CI: 9-19%) |
| India | 97% (CI: 90-99%) | 2% (CI: 0-6%) | 1% (CI: 0-3%) | 1% (CI: 0-3%) | 4% (CI: 1-9%) |
| East Asia | 73% (CI: 59-79%) | 24% (CI: 14-33%) | 3% (CI: 0-7%) | 1% (CI: 0-3%) | 31% (CI: 26-37%) |
| Africa | 95% (CI: 82-95%) | 3% (CI: 0-8%) | 1% (CI: 0-4%) | 0% (CI: 0-2%) | 10% (CI: 5-17%) |
| Total | 90% (CI: 83-90%) | 8% (CI: 5-10%) | 2% (CI: 0-3%) | 1% (CI: 0-2%) | 13% (CI: 10-16%) |
Sciatic nerve variants relative to piriformis muscle with respect to laterality
L: left; R: right; B: bilateral
a3 of the specimens (1 left, 2 right) had unclassified variants in Beaton and Anson classification. bData missing from 3 specimens
| Author(s) (publication year) | Side (left, right) | Type A | Type Β | Type C | TypeD | Total | |||||||||||
| L | R | B | L | R | B | L | R | B | L | R | B | L | R | B | Total | ||
| Parsons and Keith [ | 138 (69L, 69R) | 58 | 60 | - | 9 | 8 | - | - | - | - | 2 | 1 | - | 11, 15.9% | 9, 13% | - | 20, 14.5% |
| Ming-Tzu (1941) [ | 140 (70L, 70R) | 45 | 47 | 36 | 24 | 22 | 13 | - | - | - | 1 | 1 | - | 25, 35.7% | 23, 32.9% | 13 | 48, 34.2% |
| Nizankowski et al.α (1972) [ | 200 (99L, 101R) | 88 | 93 | - | 5 | 3 | - | - | 3 | - | 4 | 1 | - | 11, 11.1% | 8, 7.9% | - | 19, 9.5% |
| Chiba (1992) [ | 511 (254L, 254R)b | 170 | 157 | 126 | 78 | 93 | 37 | 6 | 4 | 2 | - | - | - | 84 | 100 | 39 | 183 |
| Chiba et al. (1994) [ | 442 (221L, 221R) | 148 | 137 | 113 | 68 | 80 | 35 | 5 | 4 | 2 | - | - | - | 73, 33% | 84, 38% | 37 | 157, 35.5% |
| Pokorný et al. (1998) [ | 51 (28L, 23R) | 21 | 20 | - | 4 | 3 | - | 2 | - | - | 1 | - | - | 7, 25% | 3, 13% | - | 10, 19.6% |
| Uluutku and Kurtoğlu (1999) [ | 50 (25L, 25R) | 18 | 19 | - | 4 | 4 | - | 3 | 2 | - | - | - | - | 7, 28% | 6, 24% | - | 13, 26% |
| Vincente et al. (2007) [ | 40 (20L, 20R) | 17 | 17 | 17 | 3 | 3 | 3 | - | - | - | - | - | - | 3, 15% | 3, 15% | 3 | 6, 15% |
| Gomes et al. (2014) [ | 40 (20L, 20R) | 18 | 17 | 17 | 2 | 3 | 2 | - | - | - | - | - | - | 2, 10% | 3, 15% | 2 | 5, 12.5% |
| Total | 2,572 | 583 | 567 | 309 | 214 | 224 | 100 | 16 | 14 | 4 | 7 | 3 | - | 283 | 290 | 124 | 573 |
| Total prevalence (confidence interval) | 77% (67-85) | 78% (67-88) | 62% (48-74) | 19% (12-28) | 19% (10-30) | 15% (7-26) | 2% (0-6) | 2% (0-6) | 1% (0-4) | 2% (0-5) | 1% (0-4) | 0% (0-3) | 23% (16-31) | 22% (13-32) | 16% (7-26) | ||
| I2 | 85% | 91% | 87% | 85% | 91% | 87% | 85% | 91% | 87% | 85% | 91% | 87% | 81% | 89% | 87% | ||
| Cochrane’s Q, p-value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
Sciatic nerve variants relative to piriformis muscle with respect to gender
M: males; F: females
a3 of the specimens (1 male, 2 females) had unclassified variants in Beaton and Anson classification
| Author (year of publication) | Number of samples (male, female) | Type A | Type Β | Type C | Type D | Total | ||||||
| M | F | M | F | M | F | M | F | M | F | Total | ||
| Nizankowski et al.α (1972) [ | 200 (109M, 91F) | 99, 90% | 82, 91.1% | 4, 3.63% | 4, 4.4% | 2, 1.81% | 1, 1.1% | 2, 1.81% | 3, 3.33% | 8, 7.3% | 8, 8.8% | 19, 9.5% |
| Uluutku and Kurtoğlu (1999) [ | 50 (14M, 36F) | 8, 57.14% | 29, 80.55% | 5, 35.71% | 3, 8.33% | 1, 7.14% | 4, 11.1% | - | - | 6, 42.8% | 7, 19.4% | 13, 26% |
| Gomes et al. (2014) [ | 40 (34M, 6F) | 29, 85.29% | 6, 100% | - | 5, 83.3% | - | - | - | - | 5, 14.7% | 0, 0% | 5, 12.5% |
| Total | 290 (157M, 133F) | 136, 86.62% | 117, 88.96% | 9, 5.73% | 12, 9.02% | 3, 1.91% | 5, 3.76% | 2, 1.27% | 3, 2.25% | 14, 8.91% | 20, 15.3% | 37, 12.75% |
| Total prevalence (confidence interval) | 87% (76-98%) | 82% (59-97%) | 6% (0-16%) | 13% (0-34%) | 3% (0-14%) | 5% (0-14%) | 2% (0-10%) | 2% (0-9%) | 11% (4-21%) | 18% (5-35%) | ||
| I2 | 63% | 84% | 63% | 84% | 84% | 63% | 84% | 63% | 37% | 75% | ||
| Cochrane’s Q, p-value | 0.07 | 0.00 | 0.07 | 0.00 | 0.00 | 0.07 | 0.00 | 0.07 | 0.2 | 0.02 | ||